Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.38 Million ≈ $17.18 Million USD) by net assets (CN¥15.04 Billion ≈ $2.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Zhangzhou Pientzehuang Pharmaceutical Co to measure how many days the company can operate on defensive assets alone.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Deutsche Lufthansa AG
XETRA:LHA
0.159x
Arrow Electronics Inc
NYSE:ARW
0.103x
China Aerospace Times Electronics Co Ltd
SHG:600879
0.130x
CSPC Pharmaceutical Group Limited
F:CVG
0.062x
Vietnam JSCmmercial Bank for Industry and Trade
VN:CTG
-0.013x
Raytron Technology Co Ltd
SHG:688002
0.074x
WISE PLC SPONS.ADR/1
F:6WS0
N/A
Moog Inc
NYSE:MOG-A
0.062x

Annual Cash Flow Conversion Efficiency for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Zhangzhou Pientzehuang Pharmaceutical Co market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥15.09 Billion
≈ $2.21 Billion
CN¥77.03 Million
≈ $11.27 Million
0.005x -94.23%
2024-12-31 CN¥14.84 Billion
≈ $2.17 Billion
CN¥1.31 Billion
≈ $192.24 Million
0.089x -44.15%
2023-12-31 CN¥13.92 Billion
≈ $2.04 Billion
CN¥2.21 Billion
≈ $322.90 Million
0.159x -72.73%
2022-12-31 CN¥11.82 Billion
≈ $1.73 Billion
CN¥6.87 Billion
≈ $1.01 Billion
0.581x +1174.64%
2021-12-31 CN¥10.14 Billion
≈ $1.48 Billion
CN¥462.27 Million
≈ $67.64 Million
0.046x -74.33%
2020-12-31 CN¥8.26 Billion
≈ $1.21 Billion
CN¥1.47 Billion
≈ $214.68 Million
0.178x +240.83%
2019-12-31 CN¥6.97 Billion
≈ $1.02 Billion
CN¥-879.37 Million
≈ $-128.68 Million
-0.126x -209.37%
2018-12-31 CN¥5.31 Billion
≈ $776.67 Million
CN¥612.31 Million
≈ $89.60 Million
0.115x -24.58%
2017-12-31 CN¥4.43 Billion
≈ $647.55 Million
CN¥676.93 Million
≈ $99.06 Million
0.153x +45.43%
2016-12-31 CN¥3.75 Billion
≈ $548.85 Million
CN¥394.54 Million
≈ $57.73 Million
0.105x +13.74%
2015-12-31 CN¥3.30 Billion
≈ $483.38 Million
CN¥305.51 Million
≈ $44.71 Million
0.092x +4.45%
2014-12-31 CN¥2.99 Billion
≈ $437.14 Million
CN¥264.50 Million
≈ $38.70 Million
0.089x -16.34%
2013-12-31 CN¥2.59 Billion
≈ $379.33 Million
CN¥274.34 Million
≈ $40.14 Million
0.106x +1.37%
2012-12-31 CN¥1.56 Billion
≈ $227.63 Million
CN¥162.40 Million
≈ $23.76 Million
0.104x -46.71%
2011-12-31 CN¥1.19 Billion
≈ $173.99 Million
CN¥232.95 Million
≈ $34.09 Million
0.196x +3.38%
2010-12-31 CN¥1.08 Billion
≈ $158.60 Million
CN¥205.41 Million
≈ $30.06 Million
0.190x +25.43%
2009-12-31 CN¥857.19 Million
≈ $125.43 Million
CN¥129.52 Million
≈ $18.95 Million
0.151x +803.81%
2008-12-31 CN¥752.09 Million
≈ $110.05 Million
CN¥12.57 Million
≈ $1.84 Million
0.017x -78.87%
2007-12-31 CN¥758.85 Million
≈ $111.04 Million
CN¥60.04 Million
≈ $8.79 Million
0.079x -3.09%
2006-12-31 CN¥621.09 Million
≈ $90.89 Million
CN¥50.70 Million
≈ $7.42 Million
0.082x -28.12%
2005-12-31 CN¥608.07 Million
≈ $88.98 Million
CN¥69.06 Million
≈ $10.11 Million
0.114x -37.95%
2004-12-31 CN¥539.08 Million
≈ $78.88 Million
CN¥98.67 Million
≈ $14.44 Million
0.183x +213.15%
2003-12-31 CN¥553.59 Million
≈ $81.01 Million
CN¥32.36 Million
≈ $4.73 Million
0.058x -91.42%
2002-12-31 CN¥154.81 Million
≈ $22.65 Million
CN¥105.45 Million
≈ $15.43 Million
0.681x +51.06%
2001-12-31 CN¥146.02 Million
≈ $21.37 Million
CN¥65.84 Million
≈ $9.63 Million
0.451x --

About Zhangzhou Pientzehuang Pharmaceutical Co Ltd

SHG:600436 China Drug Manufacturers - General
Market Cap
$9.97 Billion
CN¥68.11 Billion CNY
Market Cap Rank
#2274 Global
#276 in China
Share Price
CN¥112.89
Change (1 day)
-1.49%
52-Week Range
CN¥112.89 - CN¥214.25
All Time High
CN¥485.80
About

Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals… Read more